1. Tanagho Emil A, McAnich Jack W, editors.

Chapter 22: Neoplasm of the

Prostate Gland. In: Smiths General Urology, Lange Urology Book; 16 th
ed. San Fransisco: McGraw Hill Companies. 2007; p. C22.
2. Roehrborn CG, McConnell JD. Etiology, pathophysiology, epidemiology
and natural history of benign prostatic hyperplasia. In: Campbells
Urology. 9th ed. Volume 1. Philadelphia: Saunders Elsevier; 2007. p. C38.
3. Kaplan SA. AUA Guidelines and Their Impact on the Management of
BPH: Reviews in Urology 2004; 6(9). S46-52.
4. Basuki B. Purnomo, editors. Batu Saluran Kemih. In: Dasar-dasar Urologi.
3rd ed; Jakarta: Sagung Seto; 2012; p.93-101.
5. J. de la Rosette, G Alivizatos, S Madersbacher, C Rioja Sanz, J Nordling,
M. Emberton, et al. Guidelines on Benign Prostatic Hyperplasia. European
Association of Urology 2008; p. 5 59.
6. Glenn, James F, Graham, Sam D, Keane, Thomas E, editors. Section IV:
Prostate Anatomy. Glenn's Urologic Surgery. 6th ed. Lippincott Williams &
Wilkins; 2004. p. SIV.
7. Campbell, Walsh. In: Wein, Kavussi, Novick, Partin, Peters, editors.
Sections XVI: Prostate. Urology. 9th ed. Volume 1. Philadelphia:
Saunders Elsevier; 2007.
8. Ikatan Ahli Urologi Indonesia. Pedoman Penatalaksanaan BPH di
Indonesia. Available at: www.iaui.or.id/ast/file/bph.pdf. Accessed on:
November 10, 2014.
9. Kirby R, Roehrborn C, Boyle P et al: Efficacy and tolerability of
doxazosin and finasteride, alone or in combination, in treatment of
symptomatic benign prostatic hyperplasia: the Prospective European
Doxazosin and Combination Therapy (PREDICT) trial. Urology 2003; 61:
119.
10. Vallancien G, Emberton M, Alcaraz A et al: Alfuzosin 10 mg once daily
for treating benign prostatic hyperplasia: a 3-year experience in real-life
practice. BJU Int 2008; 101: 847.
11. Chung B, Hong S: Long-term follow-up study to evaluate the efficacy and
safety of the doxazosin gastrointestinal therapeutic system in patients with
benign prostatic hyperplasia with or without concomitant hypertension.
BJU Int 2006; 97: 90.
12. Roehrborn C, Siami P, Barkin J et al: The effects of dutasteride, tamsulosin
and combination therapy on lower urinary tract symptoms in men with
benign prostatic hyperplasia and prostatic enlargement: 2-year results from
the CombAT study. J Urol 2008; 179: 616.
13. Kramer B, Hagerty K, Justman S et al: Use of 5--Reductase Inhibitors for
Prostate Cancer Chemoprevention: American Society of Clinical
Oncology/American Urological Association 2008 Clinical Practice
Guideline Summary. J Clin Oncol 2009; 27: 1502.
14. Dall'Oglio M, Srougi M, Antunes A et al: An improved technique for
controlling bleeding during simple retropubic prostatectomy: a
randomized controlled study. BJU Int 2006; 98: 384.

15. Baumert H, Ballaro A, Dugardin F et al: Laparoscopic versus open simple

prostatectomy: a comparative study. J Urol 2006; 175: 1691.
16. Deliveliotis C, Liakouras C, Delis A, Skolarikos A, Varkarakis J,
Protogerou V. Prostate operations: long-term effects on sexual and urinary
function and quality of life. Comparison with an age-matched control
population. Urol Res 2004; 32: 283.
17. Michielsen D, Debacker T, De Boe V et al: Bipolar transurethral resection
in saline- an alternative surgical treatment for bladder outlet obstruction? J
Urol 2007; 178: 2035.
18. Yoon C, Kim J, Moon K et al: Transurethral resection of the prostate with
a bipolar tissue management system compared to conventional monopolar
resectoscope: one-year outcome. Yonsei Med J 2006; 47: 715.
19. Falsaperla M, Cindolo L, Saita A, Polara A, Bonaccorsi A, Scavuzzo A, et
al. Transurethral resection of prostate: technical progress by bipolar Gyrus
plasmakinetic tissue management system. Minerva Urol Nefrol 2007; 59:
125.
20. Lim KB, Wong MY, Foo KT. Transurethral resection of prostate (TURP)
through the decades -a comparison of results over the last thirty years in a
single institution in Asia. Ann Acad Med Singapore 2004; 33: 775.
21. O'Sullivan M, Murphy, C., Deasy, C., Iohom, G., Kiely, E. A., Shorten, G.:
Effects of transurethral resection of prostate on the quality of life of
patients with benign prostatic hyperplasia. J Am Coll Surg 2004; 198: 394.